Zhejiang Hisun Pharmaceutical Co., Ltd.SSE: 600267

(600267)"Zhejiang Hisun Pharmaceutical Co., Ltd."Announcement on Obtaining the Approval for Veterinary Drug Product Approval Number by Subsidiary

· Issued by Zhejiang Hisun Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 600267 · · 2 pages · Chinese

Summary by 6ix AI

Zhejiang Hisun Pharmaceutical Co., Ltd. announced that its subsidiary has received approval for a veterinary drug product.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/600267zhejiang-hisun-pharmaceutical-co-ltdannouncement-on-obtaining-the-approval-for-veterinary-drug-product-approval-number-by-subsidiary

Release

Announcement on Obtaining the Approval for Veterinary Drug Product Approval Number by Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Hisun Pharmaceutical Co., Ltd. on 6ix

Story so far

Earlier from Zhejiang Hisun Pharmaceutical

Later from Zhejiang Hisun Pharmaceutical

All Zhejiang Hisun Pharmaceutical news releases